Vildagliptin-d3 structure
|
Common Name | Vildagliptin-d3 | ||
---|---|---|---|---|
CAS Number | 1217546-82-1 | Molecular Weight | 306.41800 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C17H22D3N3O2 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of Vildagliptin-d3Vildagliptin-d3 (LAF237-d3) is the deuterium labeled Vildagliptin. Vildagliptin (LAF237) is a potent, stable, selective dipeptidyl peptidase IV (DPP-IV) inhibitor with an IC50 of 3.5 nM in human Caco-2 cells. Vildagliptin possesses excellent oral bioavailability and potent antihyperglycemic activity[1][2]. |
Name | Vildagliptin |
---|---|
Synonym | More Synonyms |
Description | Vildagliptin-d3 (LAF237-d3) is the deuterium labeled Vildagliptin. Vildagliptin (LAF237) is a potent, stable, selective dipeptidyl peptidase IV (DPP-IV) inhibitor with an IC50 of 3.5 nM in human Caco-2 cells. Vildagliptin possesses excellent oral bioavailability and potent antihyperglycemic activity[1][2]. |
---|---|
Related Catalog | |
In Vitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1]. |
References |
Molecular Formula | C17H22D3N3O2 |
---|---|
Molecular Weight | 306.41800 |
Exact Mass | 306.21400 |
PSA | 76.36000 |
LogP | 1.50308 |
(2S)-2,5,5-trideuterio-1-[2-[[(5S,7R)-3-hydroxy-1-adamantyl]amino]acetyl]pyrrolidine-2-carbonitrile |